Example

This example demonstrates additional example findings.

Rows 1-4:These findings demonstrate original results with modifiers, including a severity, which is copied into MASEV. The base gross observations are entered into MASTRESC, and the remaining modifiers are submitted in MARESMOD supplemental qualifiers.
Row 3:The left lobe is not qualifying a part of the scheduled sampled specimen (LUNG), but qualifying the finding (as it is present in MAORRES) and, therefore, belongs as a result modifier in supplemental qualifier (MARESMOD) and not in MAANTREG.
Row 4:The finding demonstrates an original result with a comment that is copied into the Comments domain (see the CO dataset in this example).
Rows 5, 10:These findings demonstrate original results without modifiers.
Row 6:This finding demonstrates the use of specimen qualifiers (MAANTREG, MALAT, and MADIR).
Row 7:This is an example of a reason why a macroscopic evaluation was not done (MAREASND). Note that MAORRES is null and MASTAT is "NOT DONE".
Row 8:Represents a normal observation applied to all examined tissues for the subject. Note the MASPEC field's value of "ALL TISSUES".
Row 9:Represents a normal observation for the cecum.

ma.xpt

ma.xpt

RowSTUDYIDDOMAINUSUBJIDMASEQMASPIDMATESTCDMATESTMAORRESMASTRESCMASTATMAREASNDMASPECMAANTREGMALATMADIRMASEVMADTCMADY
1123456MA123456-10011
GROSPATHGross Pathological ExaminationDiscoloration dark, mucosaDiscoloration

LARGE INTESTINE, CECUM



2011-03-23365
2123456MA123456-10012
GROSPATHGross Pathological ExaminationFoci dark, mucosaFoci

LARGE INTESTINE, COLON

DISTAL
2011-03-23365
3123456MA123456-10013
GROSPATHGross Pathological ExaminationCongestion, left lobe moderateCongestion

LUNG


MODERATE2011-03-23365
4123456MA123456-10014
GROSPATHGross Pathological ExaminationBulla, right caudal lobe, 1 cm in diameter, one sectionBulla

LUNG



2011-03-23365
5123456MA123456-10015
GROSPATHGross Pathological ExaminationSmallSmall

THYMUS



2011-03-23365
6123456MA123456-10026MASS 1GROSPATHGross Pathological ExaminationMass, approximately 8 mm long, 6 mm wide, 4 mm thick, pale firm well definedMass

BONE, FEMURSTIFLELEFTMEDIAL
2011-03-23365
7123456MA123456-10027
GROSPATHGross Pathological Examination

NOT DONETissue lostGLAND, PITUITARY



2011-03-23365
8123456MA123456-10038
GROSPATHGross Pathological ExaminationNo necropsy observations noted.UNREMARKABLE

ALL TISSUES



2011-03-23365
9123456MA123456-10049
GROSPATHGross Pathological ExaminationNormalUNREMARKABLE

LARGE INTESTINE, CECUM



2011-03-24366
10123456MA123456-100410
GROSPATHGross Pathological ExaminationAdhesionAdhesion

LUNG



2011-03-24366
$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

$titleHtml

suppma.xpt

RowSTUDYIDRDOMAINUSUBJIDIDVARIDVARVALQNAMQLABELQVALQORIG
1123456MA123456-1001MASEQ1MARESMODResult Modifiersdark; mucosaCOLLECTED
2123456MA123456-1001MASEQ2MARESMODResult Modifiersdark; mucosaCOLLECTED
3123456MA123456-1001MASEQ3MARESMODResult Modifiersleft lobeCOLLECTED
4123456MA123456-1001MASEQ4MARESMODResult Modifiersright caudal lobe; 1 cm in diameterCOLLECTED
5123456MA123456-1001MASEQ6MARESMODResult Modifiersapproximately 8 mm long, 6 mm wide, 4 mm thick; pale; firm; well definedCOLLECTED
$warningHtml
This table demonstrates the representation of the comment which was included in MAORRES.

co.xpt

co.xpt

RowSTUDYIDDOMAINRDOMAINUSUBJIDCOSEQIDVARIDVARVALCOVALCODTCCODY
1123456COMA123456-10011MASEQ4one section2011-03-23365
$warningHtml

Example

This example demonstrates the use of the domain to record clinical signs follow-up examinations performed at necropsy.

Rows 1-2:Represents examples of a follow-up of a clinical observation that could not be confirmed at necropsy.
Row 3:Represents an example of a follow-up of a clinical observation that was confirmed at necropsy.

ma.xpt

ma.xpt

RowSTUDYIDDOMAINUSUBJIDMASEQMATESTCDMATESTMAORRESMASTRESCMASPECMAANTREGMADTCMADY
1999123MA999123-10116CLSFUPClinical Signs Follow-upMASS NOT FOUND AT NECROPSYMASS NOT FOUND AT NECROPSY

2000-01-31T14:33:21365
2999123MA999123-10117CLSFUPClinical Signs Follow-upNOT PRESENTNOT PRESENT

2000-01-31T14:33:21365
3999123MA999123-10118CLSFUPClinical Signs Follow-upPRESENTPRESENT

2000-01-31T14:33:21365
$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

This RELREC demonstrates a linking between a specific clinical observation (CLSEQ) and its corresponding clinical sign follow-up at necropsy (MASEQ).
$titleHtml

relrec.xpt

RowSTUDYIDRDOMAINUSUBJIDPOOLIDIDVARIDVARVALRELTYPERELID
1999123CL123456
CLSEQ47
62
2999123CL123456
CLSEQ49
63
3999123CL123456
CLSEQ51
64
4999123MA123456
MASEQ16
62
5999123MA123456
MASEQ17
63
6999123MA123456
MASEQ18
64
$warningHtml
This example demonstrates a linking between findings across the Clinical Observations (CL), Palpable Masses (PM), MA, Microscopic Findings (MI), and Tumor Findings (TF) domains using RELREC. The mass was first identified as an abrasion over several weeks (grouped by CLGRPID = 5), graduating to a mass with several associated clinical findings (identified by a CLSPID of "MASS 2"). These clinical findings correspond to a set of findings in the PM domain, a clinical signs follow-up and gross pathological examination in the MA domain, a single microscopic finding from the MI domain, and a single tumor finding in the TF domain. Each of the findings in the PM, MA, MI, and TF are related by way of the --SPID field, with a value of "MASS 2".

Because all of these records are related, they are given the same RELID (in this case a value of 80).

$titleHtml

relrec.xpt

RowSTUDYIDRDOMAINUSUBJIDPOOLIDIDVARIDVARVALRELTYPERELID
1PY001002CLAA-12540
CLGRPID5
80
2PY001002CLAA-12540
CLSPIDMASS 2
80
3PY001002PMAA-12540
PMSPIDMASS 2
80
4PY001002MAAA-12540
MASPIDMASS 2
80
5PY001002MIAA-12540
MISPIDMASS 2
80
6PY001002TFAA-12540
TFSPIDMASS 2
80
$warningHtml

Example

These are example records of a macroscopic evaluation of injection sites (as indicated in FOCID).

ma.xpt

ma.xpt

RowSTUDYIDDOMAINUSUBJIDFOCIDMASEQMASPIDMASTESTCDMATESTMAORRESMASTRESCMASPECMAANTREGMALATMADIRMASEV
112345MA12345001Injection site 11
GROSPATHGross Pathological ExaminationFur thin coverFocal hair lossSKIN
LEFTDORSOCRANIAL
212345MA12345001Injection site 22
GROSPATHGross Pathological ExaminationUnremarkableUNREMARKABLESKIN
RIGHTDORSOCRANIAL
312345MA12345001Injection site 33
GROSPATHGross Pathological ExaminationFocal hemorrhageHemorrhageSKIN
LEFTDORSOCAUDAL
412345MA12345001Injection site 44MASS 1GROSPATHGross Pathological ExaminationMass, approximately 8 mm long, 4 mm thick, pale firm well definedMassSKIN
RIGHTDORSOCAUDAL
512345MA12345002Injection site 11
GROSPATHGross Pathological ExaminationUnremarkableUNREMARKABLESKIN
LEFTDORSOCRANIAL
612345MA12345002Injection site 22
GROSPATHGross Pathological ExaminationDiscoloration; subcutaneous; red; slightDiscolorationSKIN
RIGHTDORSOCRANIALMILD
712345MA12345002Injection site 33
GROSPATHGross Pathological ExaminationUnremarkableUNREMARKABLESKIN
LEFTDORSOCAUDAL
812345MA12345002Injection site 44
GROSPATHGross Pathological ExaminationMucosal hemorrhage (about 2x2 cm), moderateHemorrhageSKIN
RIGHTDORSOCAUDALMODERATE
$warningHtml
Note that the concept of "MASS 1" (in CLSPID) is different from "Injection site 1" (in FOCID), in that information in the FOCID variable is known prior to the examination, but the mass ID/applicant identifier is assigned as part of the examination. FOCID thereby qualifies the test, whereas CLSPID qualifies the result.

cl.xpt

cl.xpt

RowSTUDYIDDOMAINUSUBJIDFOCIDCLSEQCLSPIDCLTESTCDCLTESTCLCATCLORRESCLSTRESCCLLOCCLSEVCLDTCCLDYCLNOMDY
112345CL12345001Injection site 11
SKINEXSkin ExaminationCLINICAL SIGNSFur, Thin Cover; Left ScapulaFur, Thin CoverLeft Scapula
2004-07-194242
212345CL12345001Injection site 22
SKINEXSkin ExaminationCLINICAL SIGNSNo Abnormal Findings, Right ScapulaUnremarkableRight Scapula
2004-07-194242
312345CL12345001Injection site 33
SKINEXSkin ExaminationCLINICAL SIGNSNo Abnormal Findings, Left Medial BackUnremarkableLeft Medial Back
2004-07-194242
412345CL12345001Injection site 44MASS 1SKINEXSkin ExaminationCLINICAL SIGNSModerate Swelling, Right Medial BackSwellingRight Medial BackMODERATE2004-07-194242
512345CL12345002Injection site 11
SKINEXSkin ExaminationCLINICAL SIGNSNo Abnormal Findings, Left ScapulaUnremarkableLeft Scapula
2004-07-194242
612345CL12345002Injection site 22
SKINEXSkin ExaminationCLINICAL SIGNSSlight Reddening, Right ScapulaReddeningRight ScapulaMILD2004-07-194242
712345CL12345002Injection site 33
SKINEXSkin ExaminationCLINICAL SIGNSAbrasion, Left Medial BackAbrasionLeft Medial Back
2004-07-194242
812345CL12345002Injection site 44
SKINEXSkin ExaminationCLINICAL SIGNSModerate Reddening, Right Medial BackReddeningRight Medial BackMODERATE2004-07-194242
$warningHtml

  • No labels